Van Ngo Cong, Nguyen Hoang, Aklinski Joseph, Nguyen Dung My Thi, Le Hoang Huy, Le Trang Thi Bich, Nguyen Hien Quang, Huynh Hong-Han, Hanh Nhi Le Huu, Minh Le Huu Nhat
Department of Otolaryngology-Head and Neck Surgery, Cho Ray Hospital, Ho Chi Minh City, 700000 Vietnam.
Department of Foundation Science, Nova Southeastern University, The Kiran C. Patel College of Osteopathic Medicine (NSU-KPCOM), Clearwater, FL 33025 USA.
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):2850-2855. doi: 10.1007/s12070-023-03863-6. Epub 2023 May 20.
Aims: The objective of this study is to assess the effectiveness of the combined middle and inferior meatal antrostomy (MIMA) in management of patients with maxillary fungal sinusitis. Material and Methods: Design: retrospective cross sectional study. Setting and subjects: From September 2018 to March 2021, fifty-five patients with non-invasive maxillary fungal sinusitis, who underwent transnasal endoscopic combined MIMA. Methods: The study compared patients' pre- and post-operative subjective symptoms, including nasal obstruction, discharge, facial pain or pressure, halitosis, anosmia, and other non-specific symptoms. Endoscopic characteristics of recurrent fungal maxillary sinusitis and postoperative complications were also observed. Closure of the IMA site was evaluated at three and six months post-surgery and patients were categorized into three groups based on closure degree. Results: All clinical symptoms, including nasal discharge, nasal obstruction, nasal pruritus, anosmia, halitosis, sneezing, facial pain, ophthalmic and otologic symptoms, were resolved over six months after combined MIMA in majority of cases (94 - 100%). After three and six months, the postoperative endoscopic evaluation revealed recurrent fungal maxillary sinusitis in 1.8% and 5.4% of cases, respectively. Partial stenosis of the inferior antrostomy was observed in 7.2% and 16% of cases, while complete stenosis was noted in 3.6% and 7.2% of cases after three months and six months. Conclusions: The combined MIMA is effective and has better outcomes than the medial meatal antrostomy approach alone without additional operative time.
The online version contains supplementary material available at 10.1007/s12070-023-03863-6.
目的：本研究的目的是评估中鼻道和下鼻道联合鼻窦造口术（MIMA）治疗上颌窦真菌性鼻窦炎患者的有效性。材料与方法：设计：回顾性横断面研究。地点和对象：2018年9月至2021年3月，55例非侵袭性上颌窦真菌性鼻窦炎患者接受了经鼻内镜联合MIMA手术。方法：研究比较了患者术前和术后的主观症状，包括鼻塞、流涕、面部疼痛或压痛、口臭、嗅觉减退及其他非特异性症状。还观察了复发性真菌性上颌窦炎的内镜特征及术后并发症。在术后3个月和6个月评估下鼻道造口部位的闭合情况，并根据闭合程度将患者分为三组。结果：在大多数病例（94%-100%）中，联合MIMA术后6个月内所有临床症状，包括流涕、鼻塞、鼻痒、嗅觉减退、口臭、打喷嚏、面部疼痛、眼部和耳部症状均得到缓解。术后3个月和6个月，内镜评估分别显示1.8%和5.4%的病例出现复发性真菌性上颌窦炎。术后3个月和6个月，分别有7.2%和16%的病例观察到下鼻道造口部分狭窄，3.6%和7.2%的病例出现完全狭窄。结论：联合MIMA有效，与单独的中鼻道鼻窦造口术相比，效果更好，且不增加手术时间。
在线版本包含可在10.1007/s12070-023-03863-6获取的补充材料。
